Compare LADR & INDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LADR | INDV |
|---|---|---|
| Founded | 2008 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 4.7B |
| IPO Year | 2013 | 2014 |
| Metric | LADR | INDV |
|---|---|---|
| Price | $9.62 | $33.88 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $12.25 | N/A |
| AVG Volume (30 Days) | 880.3K | ★ 1.6M |
| Earning Date | 04-23-2026 | 06-08-2026 |
| Dividend Yield | ★ 8.98% | N/A |
| EPS Growth | N/A | ★ 8100.00 |
| EPS | 0.14 | ★ 1.67 |
| Revenue | N/A | ★ $1,239,000,000.00 |
| Revenue This Year | $31.66 | N/A |
| Revenue Next Year | $16.92 | N/A |
| P/E Ratio | $68.36 | ★ $20.49 |
| Revenue Growth | N/A | ★ 4.29 |
| 52 Week Low | $9.38 | $22.22 |
| 52 Week High | $11.53 | $42.81 |
| Indicator | LADR | INDV |
|---|---|---|
| Relative Strength Index (RSI) | 38.79 | 31.11 |
| Support Level | $9.43 | $33.15 |
| Resistance Level | $10.39 | $35.54 |
| Average True Range (ATR) | 0.16 | 0.81 |
| MACD | -0.03 | 0.01 |
| Stochastic Oscillator | 4.26 | 19.47 |
Ladder Capital Corp is an internally-managed real estate investment trust that is in commercial real estate finance. The company originates and invests in a diverse portfolio of commercial real estate and real estate-related assets, focusing on senior secured assets. The company's investment activities include: (i) Primary business of originating senior first mortgage fixed and floating rate loans collateralized by commercial real estate with flexible loan structures; (ii) owning and operating commercial real estate, including net leased commercial properties; and (iii) investing in investment-grade securities secured by first mortgage loans on commercial real estate. The company has three reportable segments: Loans, which derive maximum revenue; Securities; and Real Estate.
Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).